INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

Clinical trial NCT05904743 · COMPLETED

Trial details

NCT number: NCT05904743
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2023-07-07
Primary completion: 2024-03-26
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.